CEL-SCI and Saudi Amarox to Behavior Signing Rite at BIO 2026 for Strategic Settlement to Advance Commercialization and Distribution of Multikine® in Saudi Arabia
Saudi Arabia Emerges as a World Biotech Funding Hub Underneath Imaginative and prescient 2030 Senior Saudi Executive, Funding and Healthcare Leaders to Attend the CEL-SCI / Amarox Signing & Opening Ceremonies Strategic Settlement Marks Vital Step Towards Commercialization of Multikine® in Some of the Heart East’s Quickest-Rising Healthcare Markets VIENNA, Va.–(BUSINESS WIRE)–$CVM #Multikine–CEL-SCI Company (NYSE […]










